The societal role of lifelong vaccination
暂无分享,去创建一个
[1] C. Signorelli,et al. Role of vaccination in economic growth , 2015, Journal of market access & health policy.
[2] T. Szucs,et al. From population to public institutions: what needs to be changed to benefit from the full value of vaccination , 2015, Journal of market access & health policy.
[3] S. Carroll,et al. Challenges in quantifying the patient-reported burden of herpes zoster and post-herpetic neuralgia in the UK: learnings from the Zoster Quality of Life (ZQOL) study , 2013, BMC Research Notes.
[4] T. Heikkinen,et al. Burden of paediatric influenza in Western Europe: a systematic review , 2012, BMC Public Health.
[5] S. Carroll,et al. PSY34 Understanding Disease Presentation and Patient-Reported and Economic Impact of Herpes Zoster (HZ) and Post-Herpetic Neuralgia (PHN): Findings From the Zoster Quality of Life (ZQOL) Study , 2012 .
[6] K. Schmader,et al. Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective study. , 2012, Vaccine.
[7] S. Carroll,et al. PIH45 Burden of Herpes Zoster and Post-Herpetic Neuralgia: Findings from a Cross-Sectional Patient Reported Outcomes Study , 2011 .
[8] D. Bamford,et al. An empirical investigation into health sector absenteeism , 2011, Health services management research.
[9] S. Carroll,et al. Paediatric hospital admissions for rotavirus gastroenteritis and infectious gastroenteritis of all causes in England: an analysis of correlation with deprivation , 2011, Current medical research and opinion.
[10] M. Postma,et al. Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines , 2010, BMJ : British Medical Journal.
[11] C. Giaquinto,et al. Impact of community-acquired paediatric rotavirus gastroenteritis on family life: data from the REVEAL study , 2010, BMC family practice.
[12] P. Bonanni,et al. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases. , 2008, Vaccine.
[13] M. Rose,et al. Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects , 2008, The European Journal of Health Economics.
[14] F. Huet,et al. Burden of paediatric rotavirus gastroenteritis and potential benefits of a universal rotavirus vaccination programme with RotaTeq in France. , 2007, Vaccine.
[15] J. Heyse,et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. , 2006, The New England journal of medicine.
[16] S. Wagenpfeil,et al. The burden of varicella in Germany , 2004, The European Journal of Health Economics, formerly: HEPAC.
[17] J. Ehreth. The global value of vaccination. , 2003, Vaccine.
[18] S. Wagenpfeil,et al. The burden of varicella in Germany. Potential risks and economic impact. , 2004, The European journal of health economics : HEPAC : health economics in prevention and care.
[19] C. Giaquinto,et al. Varicella vaccination in Italy : an economic evaluation of different scenarios. , 2004, PharmacoEconomics.
[20] Heather Joshi,et al. Millennium Cohort Study First Survey: A User’s Guide to Initial Findings , 2004 .
[21] P. Beutels. Economic evaluation of vaccination programmes in humans: a methodological exploration with applications to hepatitis B, varicella-zoster, measles, pertussis, hepatitis A and pneumococcal vaccination , 2002 .
[22] M. Guay,et al. Burden of chickenpox on families: A study in Quebec. , 2001, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.
[23] T. Lewins,et al. Fit for purpose , 2000 .